1. Home
  2. Analysis
  3. Epclusa
  4. Amoxicillin

Epclusa and Amoxicillin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 29 people who take Epclusa and Amoxicillin. Common interactions include fatigue among females, and fatigue among males.

The phase IV clinical study analyzes what interactions people who take Epclusa and Amoxicillin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

29 people who take Epclusa and Amoxicillin together, and have interactions are studied.

What is Epclusa?

Epclusa has active ingredients of sofosbuvir; velpatasvir. Currently, eHealthMe is studying from 11,777 Epclusa users.

What is Amoxicillin?

Amoxicillin has active ingredients of amoxicillin. It is used in infection. Currently, eHealthMe is studying from 93,509 Amoxicillin users.

Number of Epclusa and Amoxicillin reports submitted per year:

Epclusa and Amoxicillin drug interactions.

Common Epclusa and Amoxicillin drug interactions by gender *:

female:

  1. Fatigue
  2. Weight decreased
  3. Blood thyroid stimulating hormone decreased
  4. Diarrhoea
  5. Dysphagia
  6. Haematochezia
  7. Mental disorder
  8. Nasopharyngitis
  9. Overdose
  10. Psychotic disorder

male:

  1. Fatigue
  2. Abdominal pain
  3. Rectal haemorrhage
  4. Bone loss
  5. Chronic kidney disease
  6. Dysuria
  7. Nephrolithiasis
  8. Osteonecrosis
  9. Renal failure
  10. Tooth loss

Common Epclusa and Amoxicillin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort

40-49:

  1. Abdominal pain
  2. Diarrhoea
  3. Enterocolitis haemorrhagic
  4. Frequent bowel movements
  5. Rectal haemorrhage
  6. Alcohol withdrawal syndrome
  7. Cellulitis
  8. Seizure

50-59:

  1. Anxiety
  2. Fatigue
  3. Anhedonia
  4. Bone density decreased
  5. Bone loss
  6. Chronic kidney disease
  7. Dysuria
  8. Emotional distress
  9. Nephrolithiasis
  10. Osteonecrosis

60+:

  1. Dysphagia
  2. Nasopharyngitis
  3. Dysuria
  4. Emotional distress
  5. Epistaxis
  6. Faeces discoloured
  7. Fatigue
  8. Heart rate increased
  9. Joint injury
  10. Osteopenia

Common conditions people have *:

  1. Hepatitis C: 7 people, 24.14%
  2. Hiv Infection: 4 people, 13.79%

* Approximation only. Some reports may have incomplete information.

Do you take Epclusa and Amoxicillin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Epclusa drug interactions:

Browse interactions between Epclusa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Amoxicillin drug interactions:

Browse interactions between Amoxicillin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir; velpatasvir and amoxicillin (the active ingredients of Epclusa and Amoxicillin, respectively), and Epclusa and Amoxicillin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Epclusa and Amoxicillin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.